CareersFind a DoctorMake an AppointmentDepartmentsDirections & ParkingGiftsContact UsPRINT

	Neurology   From the Chair   Faculty   Grand Rounds   Presentations   Research   Outpatient Clinic   Neurology Sections   Adult Residency   Pediatric Residency   Fellowships   Neurology in the News		WFUBMC Home   >    Neurology   >    Research   >    An Open-Label Extension Trial Long-Term Oral SPM 927 Title: An Open-Label Extension Trial to Determine Safety and Efficacy of Long-Term Oral SPM 927 in Patients with Partial Seizures (SP 756) Principal Investigator: Maria Sam, M.D. SPM972 open label extension, 3 years Inclusion Criteria:  Patients who have completed the SP754 trial. Epilepsy Completed Contact: Nancy Buchheimer 336-716-3961 nbuchhe@wfubmc.edu   Sponsor: Swartz

[Website Access Agreement] [Privacy Notices] [Copyright Information] [Campus Security Act]
Copyright: Wake Forest University School of Medicine and North Carolina Baptist Hospitals. All rights reserved.
Medical Center Boulevard
Winston-Salem, NC 27157
The information on this Website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. If you have a medical problem or a health-related question, consult your physician or call Health On-Call at 336-716-2255 or 1-800-446-2255.
Send Feedback	Home	Site Index
	Last Modified: 1/25/2008